Inventor · disambiguated record
Barrie J. Carter
Also filed as: CARTER BARRIE · CARTER BARRIE J
12 granted patents·4 pending applications·3,247 citations·filing 1985–2021
96Inventor score
Top patents by PatentIndex Score
16 records- 0198US7846729B2Metabolically activated recombinant viral vectors and methods for their preparation and useGENZYME CORP·Filed 2007·Granted Dec 7, 2010·75 cites·9 claims
- 0298US7785888B2Metabolically activated recombinant viral vectors and methods for their preparation and useGENZYME CORP·Filed 2006·Granted Aug 31, 2010·74 cites·6 claims
- 0398US7125717B2Metabolically activated recombinant viral vectors and methods for their preparation and useTARGETED GENETICS CORP·Filed 2003·Granted Oct 24, 2006·360 cites·20 claims
- 0498US6596535B1Metabolically activated recombinant viral vectors and methods for the preparation and useTARGETED GENETICS CORP·Filed 2000·Granted Jul 22, 2003·426 cites·29 claims
- 0597US5658776AGeneration of high titers of recombinant AAV vectorsTARGETED GENETICS CORP·Filed 1995·Granted Aug 19, 1997·529 cites·15 claims
- 0696US8093054B2Metabolically activated recombinant viral vectors and methods for their preparation and useCARTER BARRIE J·Filed 2010·Granted Jan 10, 2012·74 cites·36 claims
- 0796US4797368AAdeno-associated virus as eukaryotic expression vectorUS HEALTH·Filed 1985·Granted Jan 10, 1989·1.4k cites·4 claims
- 0891US5866696AModified adeno-associated virus vector capable of expression from a novel promoterUS HEALTH·Filed 1996·Granted Feb 2, 1999·83 cites·4 claims
- 0990US5587308AModified adeno-associated virus vector capable of expression from a novel promoterUS HEALTH·Filed 1992·Granted Dec 24, 1996·115 cites·10 claims
- 1088US5989540AModified adeno-associated virus vector capable of expression from a novel promoterUS HEALTH·Filed 1995·Granted Nov 23, 1999·62 cites·7 claims
- 1178US6165781AModified adeno-associated virus vector capable of expression from a novel promoterUS HEALTH·Filed 1999·Granted Dec 26, 2000·27 cites·8 claims
- 1274US5990279AAmino-terminally truncated cystic fibrosis transmembrane conductance regulatorUS HEALTH·Filed 1995·Granted Nov 23, 1999·28 cites·3 claims
- 1370US2019100773A1Metabolically activated recombinant viral vectors and methods for their preparation and useGENZYME CORP·Filed 2018·Application pending·0 cites
- 1462US2016168589A1Metabolically activated recombinant viral vectors and methods for their preparation and useGENZYME CORP·Filed 2015·Application pending·0 cites
- 1561US2012184602A1Metabolically activated recombinant viral vectors and methods for their preparation and useCARTER BARRIE J·Filed 2011·Application pending·0 cites
- 1654US2023075854A1Virus-free cell culturesBIOMARIN PHARM INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Barrie J. Carter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →